Today the company announced results from a newly published study which demonstrated its drug Seliciclib to be potentially effective in treating breast cancer resistant to hormone therapy. Seliciclib is currently in Phase 2 clinical trials for non-small cell lung cancer and nasopharyngeal cancer.
China INSOnline Corp is trading at .60 up .09 or 17.5%
Today the company reported 2nd quarter results: Net income up 33% for the period, Revenues edge higher across two of three segments, Six month net income is $0.11 per share. This company is making money with a P/E ratio of just over 2.
Raser Technologies Inc is trading at $1.14 up .18 or 19%
The company is up after news that it received approval for a $32.99 million grant. It announced today that the U.S. Treasury has approved its renewable energy grant application for the Company's Thermo No. 1 geothermal power plant.
No comments:
Post a Comment